Quest Diagnostics Inc

Quest Diagnostics Inc

Health CareHealth Care Equipment & Services
  • Price (USD)105.51
  • Today's Change-0.300 / -0.28%
  • Shares traded940.26k
  • 1 Year change40.06%
  • Beta0.6755
Data delayed at least 15 minutes, as of Apr 28 2017 21:02 BST.
More ▼

Events & Activity

  • DGX:NYQ price reached a new 52-week high of 105.29 at 11:30 BST
  • DGX:NYQ price reached a new 52-week high of 106.17 at 10:30 BST
  • DGX:NYQ price moved over +1.02% to 105.15
  • DGX:NYQ trading volume exceeds daily average by +20.68%

Key statistics

On Friday, Quest Diagnostics Inc (DGX:NYQ) closed at 105.51, -1.01% below its 52-week high of 106.59, set on Apr 26, 2017.
52-week range
74.04May 03 2016106.59Apr 26 2017
Markit short selling activity
Previous close105.81
Average volume1.39m
Shares outstanding136.83m
Free float136.23m
P/E (TTM)21.12
Market cap14.44bn USD
Annual div (ADY)1.80 USD
Annual div yield (ADY)1.71%
Div ex-dateApr 03 2017
Div pay-dateApr 19 2017
Data delayed at least 15 minutes, as of Apr 28 2017 21:02 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.